Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 2
2006 2
2007 4
2008 1
2009 3
2010 6
2011 6
2012 4
2013 3
2015 2
2016 3
2017 6
2018 7
2019 6
2020 6
2021 8
2022 2
2023 5
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Cholecystokinin-2 receptor targeting by [68Ga]Ga-DOTA-MGS5 PET/CT in a patient with extensive disease small cell lung cancer.
Di Santo G, Santo G, Martinovic V, Wolf D, Pircher A, Sviridenko A, Löffler-Ragg J, von Guggenberg E, Virgolini I. Di Santo G, et al. Among authors: von guggenberg e. Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2848-2849. doi: 10.1007/s00259-024-06749-z. Epub 2024 May 14. Eur J Nucl Med Mol Imaging. 2024. PMID: 38740575 Free PMC article. No abstract available.
Improved quality control of [177Lu]Lu-PSMA I&T.
Kraihammer M, Garnuszek P, Bauman A, Maurin M, Alejandre Lafont M, Haubner R, von Guggenberg E, Gabriel M, Decristoforo C. Kraihammer M, et al. Among authors: von guggenberg e. EJNMMI Radiopharm Chem. 2023 Mar 27;8(1):7. doi: 10.1186/s41181-023-00191-6. EJNMMI Radiopharm Chem. 2023. PMID: 36971890 Free PMC article.
Efficacy and safety of rechallenge with [177Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer.
Santo G, Di Santo G, Sviridenko A, Bayerschmidt S, Wirth L, Scherbauer F, Lehmann P, von Guggenberg E, Decristoforo C, Heidegger-Pircher I, Bektic J, Virgolini I. Santo G, et al. Among authors: von guggenberg e. Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):354-365. doi: 10.1007/s00259-024-06905-5. Epub 2024 Sep 3. Eur J Nucl Med Mol Imaging. 2024. PMID: 39225826 Free PMC article.
Developing Targeted Hybrid Imaging Probes by Chelator Scaffolding.
Summer D, Grossrubatscher L, Petrik M, Michalcikova T, Novy Z, Rangger C, Klingler M, Haas H, Kaeopookum P, von Guggenberg E, Haubner R, Decristoforo C. Summer D, et al. Among authors: von guggenberg e. Bioconjug Chem. 2017 Jun 21;28(6):1722-1733. doi: 10.1021/acs.bioconjchem.7b00182. Epub 2017 May 10. Bioconjug Chem. 2017. PMID: 28462989 Free PMC article.
[68Ga]NODAGA-RGD for imaging αvβ3 integrin expression.
Knetsch PA, Petrik M, Griessinger CM, Rangger C, Fani M, Kesenheimer C, von Guggenberg E, Pichler BJ, Virgolini I, Decristoforo C, Haubner R. Knetsch PA, et al. Among authors: von guggenberg e. Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1303-12. doi: 10.1007/s00259-011-1778-0. Epub 2011 Apr 13. Eur J Nucl Med Mol Imaging. 2011. PMID: 21487838
Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours.
Virgolini I, Gabriel M, Kroiss A, von Guggenberg E, Prommegger R, Warwitz B, Nilica B, Roig LG, Rodrigues M, Uprimny C. Virgolini I, et al. Among authors: von guggenberg e. Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):2072-83. doi: 10.1007/s00259-016-3395-4. Epub 2016 May 13. Eur J Nucl Med Mol Imaging. 2016. PMID: 27174220 Free PMC article. Review.
74 results